Finnrick - Ensuring a Safer and More Transparent Supply Chain
NovaPeptide

NovaPeptide

Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from NovaPeptide between 19 Mar 2026 and 18 Aug 2026. Test scores average over 6, no score below 5, and at least 6 tests warrant a confident Finnrick Rating of B (Good).

Finnrick Rating™
NovaPeptide
Retatrutide
Tested 6 Samples
Last test 18 Aug 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from NovaPeptide

Samples are tested in commercial labs

Tests Count

6

Scores

AVG7.9MIN6.0MAX10.0

Last

18 Aug 2026

First

19 Mar 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
18 Aug 2026View9.210mg9.4mg-6.0%99.70%n/a06/30/26No label / Silver crimp / Red capLab GPublic
18 Aug 2026View7.620mg17.4mg-13.0%99.80%n/a06/30/2026No label / Silver crimp / Yellow capLab GPublic
28 Apr 2026View6.830mg27.3mg-9.0%99.90%n/a(no batch ID)No Label / Silver Crimp / Red CapLab EPublic
26 Apr 2026View10.020mg19.9mg-0.5%99.90%
below LOQ
February 8, 2026No Label / Silver Crimp / Blue CapLab EPublic
19 Mar 2026View6.010mg8.76mg-12.4%99.90%n/a(no batch ID)No Label / Silver Crimp / Green CapLab EPublic
19 Mar 2026View8.020mg19.4mg-3.0%99.90%n/a(no batch ID)No Label / Silver Crimp / Blue CapLab EPublic
Test my peptides for free